"Benzazepines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds with BENZENE fused to AZEPINES.
| Descriptor ID |
D001552
|
| MeSH Number(s) |
D03.633.100.079
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Benzazepines".
Below are MeSH descriptors whose meaning is more specific than "Benzazepines".
This graph shows the total number of publications written about "Benzazepines" by people in this website by year, and whether "Benzazepines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 2 | 0 | 2 |
| 2014 | 1 | 0 | 1 |
| 2017 | 7 | 7 | 14 |
| 2018 | 4 | 2 | 6 |
| 2019 | 1 | 3 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Benzazepines" by people in Profiles.
-
Molecular Docking and Virtual Screening Based Prediction of Drugs for COVID-19. Comb Chem High Throughput Screen. 2021; 24(5):716-728.
-
Angioedema, ACE inhibitor and COVID-19. BMJ Case Rep. 2020 Sep 09; 13(9).
-
Structure-based drug designing and immunoinformatics approach for SARS-CoV-2. Sci Adv. 2020 07; 6(28):eabb8097.
-
Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: A prospective, randomized, controlled trial. Diabetes Obes Metab. 2019 05; 21(5):1177-1190.
-
Enrichment-induced differences in methamphetamine drug discrimination in male rats. Pharmacol Biochem Behav. 2019 04; 179:80-88.
-
Acclaimed anti-obesity drug fails to impress scouts for clinically important research. BMJ. 2019 01 30; 364:l464.
-
Lorcaserin Safety in Overweight or Obese Patients. N Engl J Med. 2019 01 03; 380(1):99-100.
-
Gender-related issues in the pharmacology of new anti-obesity drugs. Obes Rev. 2019 03; 20(3):375-384.
-
A Clinical Patient Reporting Tool: Giving ADPKD Patients Back Their Data. Praxis (Bern 1994). 2018 Apr; 107(8):425-434.
-
Effects of ivabradine on endothelial function, aortic properties and ventricular-arterial coupling in chronic systolic heart failure patients. Cardiovasc Ther. 2018 Jun; 36(3):e12323.